March 31, 1997
SAN DIEGO, Calif. -- Nickolas D. Hein, Vice President, Global Growth, for DowElanco has been elected to the board of directors of Mycogen Corporation (Nasdaq: MYCO) to serve until the next annual meeting. Hein replaces John L. Hagaman, DowElanco's President and Chief Executive Officer, who resigned from the board.
Hein, 52, is one of five DowElanco representatives on Mycogen's nine-member board. DowElanco, a partnership of The Dow Chemical Company and Eli Lilly & Company, acquired 46 percent of Mycogen's common stock in February 1996, and has since increased its ownership stake to 55 percent.
Hagaman said that Hein, who led the DowElanco team that negotiated the company's alliance with Mycogen, is responsible for deploying DowElanco's new technology business strategies, including licensing, alliances and acquisitions. Hein joined Dow Chemical in 1968, after earning a bachelor's degree in animal science and a master's in agricultural economics from Washington State University. He progressed through a series of sales and management positions and became Commercial Director of Ag Crops for North America for DowElanco when the partnership was formed in 1989. He assumed his current position in 1990.
Mycogen is a diversified agricultural biotechnology company that develops and markets technology-based products and provides crop protection services to control agricultural pests and improve food and fiber production. Mycogen Seeds develops and markets planting seeds for improved crop varieties with genetically enhanced insect-resistance and other value-added characteristics. Mycogen Crop Protection develops and markets environmentally compatible biopesticides and provides crop protection services to growers of high value crops in California and Arizona.
Michael Sund
Mycogen Corporation
(619) 453-8030
Last updated on March 31, 1997 by [email protected]